Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
μ Opioid Receptors
More Information »The μ opioid receptor, (also known as OP3, MOP, MOR), is a member of the opioid family of G-protein-coupled receptors that also includes κ, δ and NOP receptors. Three splice variants of the receptor (designated μ1, μ2 and μ3) have been characterized.
μ Opioid Receptor Products
Agonists |
|
Cat.No. |
Product Name / Activity |
| 1171 | DAMGO |
| Selective μ agonist | |
| 1055 | Endomorphin-1 |
| Potent and selective μ agonist | |
| 1056 | Endomorphin-2 |
| Potent and selective μ agonist | |
| 3247 | Fentanyl citrate |
| Potent and selective μ agonist | |
| 0840 | Loperamide hydrochloride |
| Peripherally acting μ agonist. Also Ca2+ channel blocker | |
| 3636 | Meptazinol hydrochloride |
| μ1 partial agonist | |
| 3958 | Oxycodone hydrochloride |
| μ-opioid receptor agonist | |
| 2024 | PL 017 |
| Selective μ opioid receptor agonist | |
| 3848 | Sinomenine hydrochloride |
| μ agonist; antinociceptive and anti-inflammatory | |
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 0898 | Clocinnamox mesylate |
| Irreversible μ antagonist | |
| 1560 | CTAP |
| Selective and potent μ antagonist | |
| 1578 | CTOP |
| Highly selective, potent μ antagonist | |
| 2601 | Cyprodime hydrochloride |
| Selective μ antagonist | |
| 0926 | β-Funaltrexamine hydrochloride |
| Irreversible μ-selective antagonist | |
| 0591 | Naloxonazine dihydrochloride |
| Selective µ1 antagonist | |
Other |
|
Cat.No. |
Product Name / Activity |
| 0516 | Etonitazenyl isothiocyanate |
| Irreversible affinity label (μ selective) | |
Related Categories
Quick Order
Find multiple products by catalog number
Pain Research Guide
Reserve your free copy
Highlights over 280 products for Pain research. Reserve copy
Appetite Modulation
Written by Sonia A. Tucci, Lynsay Kobelis & Tim Kirkham. Request a copy or view PDF today.
7-TM Receptor Signaling
Written by T. Kenakin et al
'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy
Tocris Events
Win a Kindle
5th Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders
June 23 - 26, 2013
Bath, UK